rotate infusion sites during IV infusion, thrombophlebitis
19
New cards
Cefepime (Maxipime®) interactions:
aminoglycosides
20
New cards
Imipenem (Primaxin®) Class
Carbapenem
21
New cards
Imipenem (Primaxin®) indication
infections caused by G+ cocci, G- bacilli and cocci, and mixed aerobic/anaerobic infections. Extremely broad antimicrobial spectrum
22
New cards
Imipenem (Primaxin®) MOA
Cell wall active: PBP binding causing cell lysis and death
23
New cards
Imipenem (Primaxin®) adverse effects
seizures, superinfections, hypersensitivity
24
New cards
Imipenem (Primaxin®) MOA binds to 2 PBPs:
PBP1 and PBP2
25
New cards
Imipenem (Primaxin®) interactions
valporate
26
New cards
Imipenem (Primaxin®) Note
always combined w/ cilastatin to increase half-life and tissue penetration
27
New cards
cilastatin is a
DHP-1 inhibitor
28
New cards
Vancomycin (Vancocin®) class
Glycopeptide
29
New cards
Vancomycin (Vancocin®) indication
Serious infections caused by MRSA or MRSE, or other infections caused by G+ bacteria (only)
30
New cards
Can Vancomycin (Vancocin®) be used for patients with b-lactam allergy?
Yes cause it is not a b-lactam
31
New cards
Oral form of Vancomycin (Vancocin®) is used to treat?
C. diff infections
32
New cards
Vancomycin (Vancocin®) MOA:
Cell wall active: Binds to cell wall synthesis precursor molecules, preventing elongation and cross-linking of peptidoglycan --> cell lysis and death. Doesn't bind to PBPs
Interferes with nucleic acids by inhibiting bacterial DNA gyrase, and topoisomerase IV. Prevents bacterial DNA replication and cell division processes from completing
inhibits synthesis of tetrahydrofolic acid, by blocking a different step in the synthesis than trimethoprim. able to block because of its structural similarity to PABA